Cargando…

Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer

BACKGROUNDS: High serum C-reactive protein (CRP) was found to be associated with poor prognosis in kinds of solid tumors, however, its role in the recurrent gastric cancer (RGC) is unknown. The present study aimed to explore the prognostic value of serum CRP in RGC patients. METHODS: A total 72 RGC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Fanming, Gao, Fangfang, Chen, Jun, Zheng, Rongxiu, Liu, Honggen, Li, Xiaojiang, Yang, Peiying, Liu, Geli, Jia, Yingjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342452/ https://www.ncbi.nlm.nih.gov/pubmed/27303917 http://dx.doi.org/10.18632/oncotarget.9910

Ejemplares similares

Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer
por: Kong, Fanming, et al.
Publicado: (2016)

Ring finger protein 180 is associated with biological behavior and prognosis in patients with non-small cell lung cancer
por: Liu, Honggen, et al.
Publicado: (2020)

The Current Application and Future Prospects of Astragalus Polysaccharide Combined With Cancer Immunotherapy: A Review
por: Kong, Fanming, et al.
Publicado: (2021)

Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis
por: Kong, Fanming, et al.
Publicado: (2021)

Is COVID-19 a high risk factor for lung cancer?: A protocol for systematic review and meta-analysis
por: Wu, Mingxin, et al.
Publicado: (2021)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010)

Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance
por: Kong, Fanming, et al.
Publicado: (2021)

Advances in Immunotherapy of Malignant Pleural Mesothelioma
por: Liao, Dongying, et al.
Publicado: (2021)

Advances in Antibody-Drug Conjugates in the Treatment of HER2-Positive Breast Cancer
por: Yu, Yongchao, et al.
Publicado: (2022)

High serum Ephrin-B2 levels predict poor prognosis for patients with gastric cancer
por: Yue, Wen-Jing, et al.
Publicado: (2018)

Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

Combination of Brachytherapy with Iodine-125 Seeds and Systemic Chemotherapy versus Systemic Chemotherapy Alone for Synchronous Extracranial Oligometastatic Non-Small Cell Lung Cancer
por: Li, Huzi, et al.
Publicado: (2020)

Lentinan combined with cisplatin for the treatment of non-small cell lung cancer
por: Zhao, Chenchen, et al.
Publicado: (2021)

Long Noncoding RNA: Shining Stars in the Immune Microenvironment of Gastric Cancer
por: Xiao, Xian, et al.
Publicado: (2022)

Low FAT4 expression is associated with a poor prognosis in gastric cancer patients
por: Jiang, Xiaoting, et al.
Publicado: (2017)

The Clinical Observation of Acupuncture Combined With Antiemetic Drugs in the Prevention and Treatment of CINV in Breast Cancer Patients
por: Kong, Fanming, et al.
Publicado: (2022)

Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis
por: de Martino, M, et al.
Publicado: (2012)

Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma
por: Wang, Jun-Ye, et al.
Publicado: (2012)

Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients
por: Chen, Zhan-hong, et al.
Publicado: (2018)

Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis
por: Yang, Mu, et al.
Publicado: (2016)

Elevated Expression of Calpain-4 Predicts Poor Prognosis in Patients with Gastric Cancer after Gastrectomy
por: Peng, Peike, et al.
Publicado: (2016)

Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer
por: Li, Shengnan, et al.
Publicado: (2022)

Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric Cancer
por: Kang, Yue, et al.
Publicado: (2015)

Overexpression of serum extracellular vesicle microRNA-215-5p is associated with early tumor recurrence and poor prognosis of gastric cancer
por: Zhang, Yunfei, et al.
Publicado: (2021)

Upregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer
por: TANG, ZHONGZHU, et al.
Publicado: (2015)

Elevated Serum Chloride Levels Contribute to a Poor Prognosis in Patients with IgA Nephropathy
por: Zhai, Yaling, et al.
Publicado: (2021)

Research Progress of Antibody–Drug Conjugate Therapy for Advanced Gastric Cancer
por: Wang, Na, et al.
Publicado: (2022)

Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy
por: Liu, Peng, et al.
Publicado: (2015)

Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma
por: Zhou, Qiang-Hua, et al.
Publicado: (2018)

Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis
por: Liu, Jingjing, et al.
Publicado: (2021)

Elevated Serum Complement C1q Levels After Traumatic Brain Injury and Its Association with Poor Prognosis
por: Yan, Xin-Jiang, et al.
Publicado: (2022)

Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation
por: Fu, Shun-Jun, et al.
Publicado: (2016)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

Elevated serum HER‐2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression
por: Zheng, Hui, et al.
Publicado: (2019)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Postoperative fever predicts poor prognosis of gastric cancer
por: Feng, Fan, et al.
Publicado: (2017)

Decreased expression of STING predicts poor prognosis in patients with gastric cancer
por: Song, Shushu, et al.
Publicado: (2017)

Elevated mean platelet volume predicts poor prognosis in colorectal cancer
por: Li, Na, et al.
Publicado: (2017)

Preoperative elevation of serum C – reactive protein is predictive for prognosis in myeloma bone disease after surgery
por: Zahlten-Hinguranage, A, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_orb72as2u0gu36hdl68rd9qlb0